Drug intelligence / Profile preview

psilocybin

Development stage
Phase 3
Lead developer
COMPASS Pathways
Modality
Small Molecules
Administration
Oral
01

Overview

**Psilocybin** is a naturally occurring psychedelic tryptamine alkaloid and phosphorylated prodrug of psilocin. After administration, it is rapidly dephosphorylated to psilocin, which primarily produces psychedelic and potentially therapeutic effects through agonism of the serotonin 2A receptor. Pharmaceutical-grade natural and synthetic psilocybin products are being developed with structured psychological support for treatment-resistant depression, major depressive disorder, alcohol use disorder, adjustment disorder in palliative care, fibromyalgia, Parkinson's disease-associated depression, post-traumatic stress disorder, and other neuropsychiatric conditions. Psilocybin itself is a single chemical entity; proprietary products such as COMP360 and natural-extract capsules are distinct drug-product formulations of the same active ingredient.

Brand names
Indocybin
Other names
psilocybine4-phosphoryloxy-N,N-dimethyltryptamine4-PO-DMTO-phosphoryl-4-hydroxy-N,N-dimethyltryptamine
02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR2B (5-Hydroxytryptamine Receptor 2B)

Beyond the preview

Go deeper on psilocybin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on psilocybin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call